HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Danielli Geraldelli Selected Research

botryosphaeran

2/2022Antioxidant, anti-inflammatory and beneficial metabolic effects of botryosphaeran [(1→3)(1→6)-β-d-glucan] are responsible for its anti-tumour activity in experimental non-obese and obese rats bearing Walker-256 tumours.
12/2020Botryosphaeran, a (1 → 3)(1 → 6)-β-D-glucan, reduces tumor development and cachexia syndrome in obese male rats by increasing insulin sensitivity and FOXO3a activity.
7/2020Tumor development in rats and cancer cachexia are reduced by treatment with botryosphaeran by increasing apoptosis and improving the metabolic profile.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Danielli Geraldelli Research Topics

Disease

2Obesity
02/2022 - 12/2020
2Macrocytic Anemia
12/2020 - 07/2020
2Cachexia
12/2020 - 07/2020
2Neoplasms (Cancer)
12/2020 - 07/2020
1Inflammation (Inflammations)
02/2022
1Body Weight (Weight, Body)
12/2020
1Insulin Resistance
12/2020

Drug/Important Bio-Agent (IBA)

3botryosphaeranIBA
02/2022 - 07/2020
2Proteins (Proteins, Gene)FDA Link
12/2020 - 07/2020
2Biological ProductsIBA
12/2020 - 07/2020
1Thiobarbituric Acid Reactive SubstancesIBA
02/2022
1Interleukin-10 (Interleukin 10)IBA
02/2022
1SugarsIBA
12/2020
1HDL CholesterolIBA
07/2020
1Triglycerides (Triacylglycerol)IBA
07/2020
1LipidsIBA
07/2020
1Glucose (Dextrose)FDA LinkGeneric
07/2020